CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Big Deal
TPG Unwinds Intersect Stake in $12 Billion Split Sale to Google: A Blueprint for AI-Era Infrastructure Monetization
The race for scalable, clean energy to fuel the Artificial Intelligence boom has culminated in a landmark transaction. TPG Rise Climate, the firm's dedicated climate investing platform, confirmed the completion of its sale of its stake in Intersect...
Ackman Unveils Dual-Listing Strategy to Publicly List Pershing Square, Targeting $10 Billion Raise
Billionaire investor Bill Ackman has initiated his long-anticipated move to bring his activist investment firm, Pershing Square Capital Management, onto public markets via a filing with the U.S. Securities and Exchange Commission on Tuesday. The...
Tencent Re-Engages in $110 Billion Paramount-WBD Megadeal as Passive Investor Amid Regulatory Headwinds
In a significant development reshaping the media landscape, Tencent Holdings is reportedly contemplating a fresh, smaller investment in Paramount Skydance’s $110 billion acquisition of Warner Bros. Discovery (WBD). This potential fresh capital...
Geopolitical Shock Wave: Latest M&A Delays Tied to Volatility in the Middle East
The tentative rebound in global Mergers & Acquisitions activity, which gained footing in the latter half of 2025, is now encountering significant headwinds driven by the escalating military conflict involving Iran. For dealmakers navigating an...
Netflix Re-Engages in Strategic M&A, Acquiring Ben Affleck’s AI Firm InterPositive
By A Wall Street Journal Reporter | Published March 5, 2026 Netflix has quietly re-entered the strategic acquisition arena, announcing the purchase of InterPositive, an artificial-intelligence filmmaking technology company founded by Academy...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Medtronic Locks in Full Neurovascular Workflow with $550M Scientia Vascular Acquisition
Galway, Ireland — Medtronic has moved decisively in the first quarter of 2026 to fortify its high-stakes neurovascular franchise, announcing a definitive agreement to acquire Scientia Vascular for approximately $550 million, inclusive of...
Agilent Clinches $950 Million Biocare Medical Buyout, Signaling Strategic Shift in Cancer Diagnostics Market
March 9, 2026 — Agilent Technologies Inc. today announced a definitive agreement to acquire Biocare Medical, a high-growth leader in specialized pathology solutions, from an investor group led by Excellere Partners and GHO Capital Partners LLP....
Servier Clinches Day One Biopharma for $2.5 Billion, Solidifying Rare Oncology Foothold
French pharmaceutical giant Servier has moved decisively to bolster its targeted therapy pipeline, announcing a definitive agreement to acquire Day One Biopharmaceuticals (NASDAQ: DAWN) in an all-cash transaction valued at approximately \$2.5...
Sanofi Divests Brazilian Generics Unit Medley to EMS in Strategic Exit
Paris-headquartered pharmaceutical giant Sanofi has agreed to divest its Brazilian generics unit, Medley, to local drugmaker EMS, in a move signaling further streamlining of its global portfolio and a calculated retreat from non-core assets in...
Novo’s $2.1B Vivtex Deal Boosts Obesity Drug Pipeline
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to expand beyond injectable GLP-1 therapies like Wegovy. ...
